The global central lab market was valued at approximately USD 3.46 billion in 2024 and is projected to reach USD 5.04 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6.56% from 2025 to 2030. This growth is primarily driven by increasing investments in research and development, as well as a heightened focus from sponsors and investigators on minimizing research costs.
Additionally, the rising trend of pharmaceutical and biotechnology companies outsourcing laboratory services to lower overall research expenses further supports market expansion during the forecast period. The increased emphasis on diagnostics, particularly due to the COVID-19 pandemic, has led to a surge in funding for innovative diagnostic solutions. For instance, according to the LabCentral 2022 Impact Report, companies raised USD 6.05 billion in funding in April 2023, which included 21% of all early-stage funding globally. This funding facilitated the dosing of 4,504 participants across 37 clinical trials and the granting of 56 patents, indicating a growing demand for central laboratory services in clinical studies.
Moreover, in March 2021, Bio-Techne Corporation launched a new R&D and manufacturing facility in Minneapolis focused on immunoassay production, specifically for ELLA immunoassay cartridges aimed at rapid biomarker detection. Such initiatives enhance the availability of immunoassay test kits, crucial for diagnosing infectious respiratory diseases throughout the forecast period.
Key Market Trends & Insights
- North America led the global central lab market with a 40.82% share in 2024.
- The Asia Pacific region is anticipated to experience the highest CAGR of 7.82% during the forecast period.
- In terms of services, the biomarker services segment captured the largest share at 38.54% in 2024.
- By end-use, pharmaceutical companies represented the largest market segment with a 44.78% share in 2024.
Order a free sample PDF of the Central Lab Market Intelligence Study, published by Grand View Research.
Market Size & Forecast
- 2024 Market Size: USD 3.46 Billion
- 2030 Projected Market Size: USD 5.04 Billion
- CAGR (2025-2030): 6.56%
- North America: Largest market in 2023
Key Companies & Market Share Insights
Offers Key players operating in the central lab market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.
Key Players
- ACM Global Laboratories
- Labconnect
- Cerba Research
- Eurofins Scientific
- Medicover Integrated Clinical Services (MICS) (Synevo Central Labs
- Versiti (Cenetron)
- A.P. Møller Holding A/S (Unilabs)
- Ampersand Capital Partners (Pacific Biomarkers)
- Lambda Therapeutics Research Ltd
- Cirion Biopharma Research Inc.
Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.
Conclusion
The central lab market is on an upward trajectory, driven by increased R&D investments, outsourcing trends, and a focus on innovative diagnostics. As stakeholders continue to prioritize cost-effective solutions, the demand for central laboratory services is expected to rise significantly. The establishment of new facilities and funding for advanced diagnostics further positions the market for growth, making it a pivotal sector in the healthcare landscape.